Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tenon Medical (TNON) Shares Outstanding (Diluted Average) (2021 - 2025)

Tenon Medical (TNON) has 5 years of Shares Outstanding (Diluted Average) data on record, last reported at $6581.0 in Q3 2025.

  • For Q3 2025, Shares Outstanding (Diluted Average) rose 1056.59% year-over-year to $6581.0; the TTM value through Sep 2025 reached $6581.0, up 1056.59%, while the annual FY2024 figure was $1214.0, 434.8% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $6581.0 in Q3 2025 per TNON's latest filing, down from $7591.0 in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $8422.0 in Q2 2022 and bottomed at $197.0 in Q3 2023.
  • Average Shares Outstanding (Diluted Average) over 5 years is $2035.9, with a median of $885.5 recorded in 2021.
  • Peak YoY movement for Shares Outstanding (Diluted Average): plummeted 85.57% in 2023, then skyrocketed 1518.55% in 2025.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $903.0 in 2021, then dropped by 11.3% to $801.0 in 2022, then crashed by 71.66% to $227.0 in 2023, then skyrocketed by 434.8% to $1214.0 in 2024, then soared by 442.09% to $6581.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Diluted Average) were $6581.0 in Q3 2025, $7591.0 in Q2 2025, and $3597.0 in Q1 2025.